Clearly, I disagree. MON just completed a fiscal year in which non-GAAP EPS increased 25% YoY, and it issued EPS guidance for FY2013 of $4.18-4.32—15% growth vs FY2012 at the midpoint of the range.
Moreover, I’ve yet to hear anyone tell me how the world will feed its growing population without the incremental yield generated by biotechnology. Whether you realize it or not, by opposing GM crops you are implicitly mandating that some people somewhere will have to go hungry.
Market Data 
Markets 
AI
